Burdock and Blood Pressure in African-American Women
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02511860|
Recruitment Status : Unknown
Verified July 2015 by Proactive Health Labs.
Recruitment status was: Not yet recruiting
First Posted : July 30, 2015
Last Update Posted : July 30, 2015
|Condition or disease||Intervention/treatment||Phase|
|Hypertension||Dietary Supplement: Burdock Dietary Supplement: Placebo||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||60 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Burdock and Blood Pressure in African-American Women: A Randomized Controlled Trial|
|Study Start Date :||August 2015|
|Estimated Primary Completion Date :||November 2015|
|Estimated Study Completion Date :||February 2016|
Placebo Comparator: Placebo
Patients will consume a placebo pill containing methylcellulose.
Dietary Supplement: Placebo
Methylcellulose (inert) tablet taken as placebo
Active Comparator: Active
Patients will consume 850 mg of burdock twice per day.
Dietary Supplement: Burdock
Subjects will consume burdock daily and will undergo laboratory tests to determine the effect of burdock, if any, on organ function.
Other Name: Arctium lappa
- Blood pressure [ Time Frame: 6 weeks ]
- Body fat percentage [ Time Frame: 6 Weeks ]
- Extracellular/Total Body Water Ratio [ Time Frame: 6 Weeks ]
- Hemoglobin A1c [ Time Frame: 6 weeks ]
- Blood urea nitrogen [ Time Frame: 6 weeks ]
- Creatinine [ Time Frame: 6 weeks ]
- Fasting Blood Glucose [ Time Frame: 6 weeks ]
- Liver function tests [ Time Frame: 6 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02511860
|Contact: Dr De||3108995577 ext email@example.com|
|Principal Investigator:||Dr. De||Proactive Health Labs|